Future Financial Wealth Managment LLC Invests $130,000 in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Future Financial Wealth Managment LLC acquired a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,000 shares of the real estate investment trust’s stock, valued at approximately $130,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cibc World Markets Corp bought a new stake in Sabra Health Care REIT during the 4th quarter valued at about $1,103,000. Hancock Whitney Corp boosted its stake in Sabra Health Care REIT by 1.9% in the 4th quarter. Hancock Whitney Corp now owns 203,668 shares of the real estate investment trust’s stock worth $2,906,000 after purchasing an additional 3,894 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in Sabra Health Care REIT during the 4th quarter valued at approximately $41,000. Creekmur Asset Management LLC acquired a new stake in Sabra Health Care REIT during the 4th quarter valued at approximately $205,000. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Sabra Health Care REIT by 12.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 24,427 shares of the real estate investment trust’s stock valued at $349,000 after purchasing an additional 2,786 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Health Care REIT Stock Down 0.9 %

SBRA opened at $17.89 on Wednesday. Sabra Health Care REIT, Inc. has a fifty-two week low of $12.83 and a fifty-two week high of $19.32. The business has a 50-day moving average of $17.38 and a 200-day moving average of $15.65. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.27 and a quick ratio of 4.27. The company has a market capitalization of $4.19 billion, a PE ratio of 89.45, a price-to-earnings-growth ratio of 2.58 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.24). The firm had revenue of $176.14 million for the quarter, compared to analyst estimates of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. Sabra Health Care REIT’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.34 EPS. Equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were paid a $0.30 dividend. The ex-dividend date of this dividend was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a yield of 6.71%. Sabra Health Care REIT’s payout ratio is 600.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Citigroup raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and increased their price target for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Scotiabank upped their target price on shares of Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Finally, Truist Financial increased their price target on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $17.80.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.